company background image
A060280 logo

Curexo KOSDAQ:A060280 Stock Report

Last Price

₩10.30k

Market Cap

₩421.6b

7D

3.2%

1Y

-33.0%

Updated

07 Feb, 2025

Data

Company Financials

A060280 Stock Overview

Engages in the development and sale of medical devices in South Korea and internationally. More details

A060280 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Curexo Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Curexo
Historical stock prices
Current Share Price₩10,300.00
52 Week High₩16,440.00
52 Week Low₩5,830.00
Beta0
1 Month Change40.14%
3 Month Change53.27%
1 Year Change-32.99%
3 Year Change37.70%
5 Year Change94.34%
Change since IPO192.61%

Recent News & Updates

Recent updates

Shareholder Returns

A060280KR Consumer RetailingKR Market
7D3.2%0.5%0.2%
1Y-33.0%-17.4%-4.9%

Return vs Industry: A060280 underperformed the KR Consumer Retailing industry which returned -17.4% over the past year.

Return vs Market: A060280 underperformed the KR Market which returned -4.9% over the past year.

Price Volatility

Is A060280's price volatile compared to industry and market?
A060280 volatility
A060280 Average Weekly Movement12.8%
Consumer Retailing Industry Average Movement5.7%
Market Average Movement6.9%
10% most volatile stocks in KR Market13.0%
10% least volatile stocks in KR Market3.5%

Stable Share Price: A060280's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A060280's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1992n/aJaejun Leewww.curexo.com

Curexo Inc. engages in the development and sale of medical devices in South Korea and internationally. It operates through Medical Robot, Implant, and Trading divisions. The company’s products include artificial joint surgery robots, such as CUVIS-joint, ROBODOC, and TSolution One surgical systems; CUVIS-spine, a navigation-based spine surgery robot; Morning Walk S200, a walking rehabilitation robot system; and InMotion Arm, a robotic rehabilitation device used in upper limb rehabilitation.

Curexo Inc. Fundamentals Summary

How do Curexo's earnings and revenue compare to its market cap?
A060280 fundamental statistics
Market cap₩421.58b
Earnings (TTM)-₩16.15b
Revenue (TTM)₩27.85b

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A060280 income statement (TTM)
Revenue₩27.85b
Cost of Revenue₩25.15b
Gross Profit₩2.70b
Other Expenses₩18.85b
Earnings-₩16.15b

Last Reported Earnings

Sep 30, 2016

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did A060280 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 10:42
End of Day Share Price 2025/02/07 00:00
Earnings2016/09/30
Annual Earnings2015/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Curexo Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jayaprabha DhavaleVirtua Research Inc.
Jin-Hyoeng ParkYuanta Securities Korea Co., Ltd.